■irSbO R&S 041363 toxicology and applied pharmacology 44.391-399 (1978) Comparison of the Fate of Vinyl Chloride following Single And Repeated Exposure in Rats P. G. Watanabe.1 J. A. Zempel, and P. J. Gehring Toxicology Research Laboratory, Health and Environmental Research, Dow Chemical U-S-A., Midland, Michigan 48640 Received July II, 1977; accepted October 19.1977 Comparison of the Fate of Vinyl Chloride following Single and Repeated Exposure in Rats. Watanabe. P. G.. Zempel. J. A, and Gehring. P. J. (1978). Toxicol. Appl. Pharmacol. 44. 391-399. Rats were exposed by inhalation to 5000 ppm of nonlabclcd vinyl chloride (VC) 6 hr/day, 5 days/week for 7 weeks. On the last day of repeated exposure UC-labeled VC was used. The fate of the I l4C I VC was compared in a group of rats exposed repeatedly to a group exposed simultaneously for a single 6 hr period to 5000 ppm of |'*C|VC, The routes and rates of excretion of MC activity were the same for the two experimental groups. The activity of microsomal enzymes, as reflected by aniline hydroxylase and p-nitroanisole O-demeihylasc derived from 9000 g liver supernatants, was essentially the same in rats exposed once or repeatedly or in nonexposed control rats. Covalent binding to hepatic macromolecules was greater in rats repeatedly exposed as compared to those subjected to a single exposure. These results indicate that repeated exposure to VC does not induce its biotransformation. However, the increase in hepatic macromolccular binding indicates that repeated exposure augments the reaction of electrophilic metabolites with macromolecules, and this may be expected to enhance potential toxicity including carcinogenicity. While many pharmacokinetic and metabolic studies have been conducted on vinyl chloride (VC), most of these investigations have concentrated on the fate of VC during and following single exposure. Since cancer has been induced by long-term repeated exposure of both experimental animals and man to VC, it is important to consider alterations in the disposition of VC in the body which may occur after repeated exposure. In preliminary studies, monochtoroacciic acid was tentatively identified as a major urinary metabolite following repeated exposure (6 hr/day, 5 days/week for 9 weeks) to 5000 ppm of nonlabcled VC (Hefner el al„ 1975). However, this metabolite has not been found in rats given a single exposure to lIJC|VC (Watanabe et a/., 1976). This raised the question of whether the biotransformation of VC may be altered upon repeated exposure. A change in the biotransformation of VC after repeated exposure is particularly important in assessing the hazard of exposure to VC since evidence suggests that VC is metabolized to a reactive metabolite which is ultimately responsible for its toxic manifestations. This concept is supported by studies showing an enhancement of the 1 To whom correspondence should be sent. .'91